Comparative study of mupirocin versus topical fusidic acid in eradication of nasal carriage of Staphylococcus aureus in patients with chronic renal failure on hemodialysis by indwelling catheter. [Estudio comparativo de mupirocina versus acido fusidico tipico en la erradicacion de portadores nasales de Staphylococcus aureus en pacientes con insuficiencia renal cronica en hemodialisis por cateter permanente]

Trial Profile

Comparative study of mupirocin versus topical fusidic acid in eradication of nasal carriage of Staphylococcus aureus in patients with chronic renal failure on hemodialysis by indwelling catheter. [Estudio comparativo de mupirocina versus acido fusidico tipico en la erradicacion de portadores nasales de Staphylococcus aureus en pacientes con insuficiencia renal cronica en hemodialisis por cateter permanente]

Recruiting
Phase of Trial: Phase III

Latest Information Update: 11 Dec 2012

At a glance

  • Drugs Fusidic acid (Primary) ; Mupirocin (Primary)
  • Indications Catheter infections; Staphylococcal infections
  • Focus Therapeutic Use
  • Most Recent Events

    • 28 Aug 2011 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top